243 related articles for article (PubMed ID: 77716)
1. Treatment of advanced Hodgkin's disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide (ABVD) after failure of MOPP therapy.
Krikorian JG; Portlock CS; Rosenberg SA
Cancer; 1978 Jun; 41(6):2107-11. PubMed ID: 77716
[TBL] [Abstract][Full Text] [Related]
2. Combination chemotherapy of MOPP-resistant Hodgkin's disease with adriamycin, bleomycin, dacarbazine and vinblastine (ABDV).
Case DC; Young CW; Lee BJ
Cancer; 1977 Apr; 39(4):1382-6. PubMed ID: 66972
[TBL] [Abstract][Full Text] [Related]
3. Randomized comparison of ABVD and MOPP/ABV hybrid for the treatment of advanced Hodgkin's disease: report of an intergroup trial.
Duggan DB; Petroni GR; Johnson JL; Glick JH; Fisher RI; Connors JM; Canellos GP; Peterson BA
J Clin Oncol; 2003 Feb; 21(4):607-14. PubMed ID: 12586796
[TBL] [Abstract][Full Text] [Related]
4. Doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) salvage of mechlorethamine, vincristine, prednisone, and procarbazine (MOPP)-resistant advanced Hodgkin's disease.
Piga A; Ambrosetti A; Todeschini G; Cetto G; Perona G; Cellerino R
Cancer Treat Rep; 1984; 68(7-8):947-51. PubMed ID: 6204754
[TBL] [Abstract][Full Text] [Related]
5. Prolonged disease-free survival in MOPP-resistant Hodgkin's disease after treatment with adriamycin, bleomycin, vinblastine and dacarbazine (ABVD).
Santoro A; Bonadonna G
Cancer Chemother Pharmacol; 1979; 2(2):101-5. PubMed ID: 93984
[TBL] [Abstract][Full Text] [Related]
6. New multiple-agent chemotherapy (B-DOPA) for advanced Hodgkin's disease.
Lokich JJ; Frei E; Jaffe N; Tullis J
Cancer; 1976 Aug; 38(2):667-71. PubMed ID: 61797
[TBL] [Abstract][Full Text] [Related]
7. Combination chemotherapy of Hodgkin's disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide versus MOPP.
Bonadonna G; Zucali R; Monfardini S; De Lena M; Uslenghi C
Cancer; 1975 Jul; 36(1):252-9. PubMed ID: 54209
[TBL] [Abstract][Full Text] [Related]
8. Salvage chemotherapy in Hodgkin's disease irradiation failures: superiority of doxorubicin-containing regimens over MOPP.
Santoro A; Viviani S; Villarreal CJ; Bonfante V; Delfino A; Valagussa P; Bonadonna G
Cancer Treat Rep; 1986 Mar; 70(3):343-8. PubMed ID: 2420444
[TBL] [Abstract][Full Text] [Related]
9. ABVD treatment of MOPP failures in Hodgkin's disease: a re-examination of goals of salvage therapy.
Clamon GH; Corder MP
Cancer Treat Rep; 1978 Mar; 62(3):363-7. PubMed ID: 77188
[No Abstract] [Full Text] [Related]
10. MOPP treatment of resistant Hodgkin's disease following ABVD failure.
Cimino G; Anselmo AP; Marzullo A; Maurizi Enrici R; Mauro F; Papa G; Mandelli F
Tumori; 1983 Oct; 69(5):469-72. PubMed ID: 6196891
[TBL] [Abstract][Full Text] [Related]
11. Combined chemotherapy (MOPP or ABVD)-radiotherapy approach in advanced Hodgkin's disease.
Bonadonna G; Zucali R; De Lena M; Valagussa P
Cancer Treat Rep; 1977 Aug; 61(5):769-77. PubMed ID: 70270
[No Abstract] [Full Text] [Related]
12. Can MOPP be replaced in the treatment of advanced Hodgkin's disease?
Canellos GP
Semin Oncol; 1990 Feb; 17(1 Suppl 2):2-6. PubMed ID: 1689509
[TBL] [Abstract][Full Text] [Related]
13. Advanced Hodgkin's disease: ABVD is better, yet is not good enough!
Diehl V
J Clin Oncol; 2003 Feb; 21(4):583-5. PubMed ID: 12586791
[No Abstract] [Full Text] [Related]
14. The treatment of advanced hodgkin's disease.
Straus DJ; Lee BJ; Koziner B; Nisce LZ; Young CW; Clarkson BD
Blut; 1981 Aug; 43(2):119-24. PubMed ID: 6167303
[TBL] [Abstract][Full Text] [Related]
15. Treatment of MOPP-resistant Hodgkin's disease with adriamycin, bleomycin, vinblastine and dacarbazine (ABVD).
Papa G; Mandelli F; Anselmo AP; De Luca AM; Maurizienrici R; Mauro F; Testi AM; Amadori S; Biagini C
Eur J Cancer Clin Oncol; 1982 Sep; 18(9):803-6. PubMed ID: 6185342
[No Abstract] [Full Text] [Related]
16. Pediatric Hodgkin's disease.
Oliapuram Jose B; Koerner P; Bertolone S; Patel CC; Spanos WJ; Paris KJ; Silverman CL; Yashar CM
J Ky Med Assoc; 2004 Mar; 102(3):104-6. PubMed ID: 15067795
[TBL] [Abstract][Full Text] [Related]
17. [Post-MOPP chemotherapy of Hodgkin's disease (author's transl)].
Osieka R; Bruntsch U; Gallmeier WM; Seeber S; Schmidt CG
Dtsch Med Wochenschr; 1976 Aug; 101(32):1177-82. PubMed ID: 59661
[TBL] [Abstract][Full Text] [Related]
18. [Successful chemotherapy of cancer. Remission of Hodgkin's disease. IV].
Lopez M
Clin Ter; 2001; 152(3):203-6. PubMed ID: 11692542
[No Abstract] [Full Text] [Related]
19. [Feasibility study of application of international prognostic score on prediction of prognosis for advanced Hodgkin's lymphoma].
Fu XH; Wang SS; Huang Y; Wang B; Huang HQ; Zhang L; Sun XF; Xu RH; Lin TY
Ai Zheng; 2006 Aug; 25(8):1013-8. PubMed ID: 16965685
[TBL] [Abstract][Full Text] [Related]
20. Treatment of advanced Hodgkin's disease with B-CAVE following MOPP failure.
Porzig KJ; Portlock CS; Robertson A; Rosenberg SA
Cancer; 1978 May; 41(5):1670-5. PubMed ID: 77180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
